Local websites
Businesses
Other websites
General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

More information

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

More information

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

More information

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Media contacts

Find contact information for media inquiries. »

Novartis newsrooms

Explore links to the Newsrooms of Novartis divisions and businesses including Animal Health, CIBA Vision, Oncology, Sandoz, Vaccines & Diagnostics, and Research functions. »

Product related info center

Our positions, updates, frequently asked questions, and backgrounders on some of our products. »

Media library

Visit our media library

Media releases

25-Apr-2013
Novartis signs on to support Malaria No More's Power of One campaign to stride towards a future without malaria

24-Apr-2013
Novartis discloses compensation for new Chairman and Chairman ad-interim

24-Apr-2013
Novartis delivered solid performance in the first quarter, with eight key regulatory approvals and all divisions contributing to growth

Featured news

Get the latest on Novartis through recent headlines, feature stories and videos. »

Corporate publications

Download or order key corporate publications. »

Stay up-to-date

Stay up-to-date on the latest news and information from Novartis. »

Top links
Top downloads
Q1 results 2013

Novartis announced its results for the first quarter of 2013 on April 24 ›

Annual report 2012

Annual report 2012 >